
Seokheun “Sean” Choi, an associate professor of electrical and computer engineering, has developed a new device for faster testing of antibiotic-resistant bacteria.
Bacterial infections have become one of the biggest health problems worldwide, and a recent study shows that COVID-19 patients have a much greater chance of acquiring secondary bacterial infections, which significantly increases the mortality rate.
Combatting the infections is no easy task, though. When antibiotics are carelessly and excessively prescribed, that leads to the rapid emergence and spread of antibiotic-resistant genes in bacteria — creating an even larger problem. According to the Centers for Disease Control and Prevention, 2.8 million antibiotic-resistant infections happen in the U.S. each year, and more than 35,000 people die from of them.
One factor slowing down the fight against antibiotic-resistant bacteria is the amount of time needed to test for it. The conventional method uses extracted bacteria from a patient and compares lab cultures grown with and without antibiotics, but results can take one to two days, increasing the mortality rate, the length of hospital stay and overall cost of care.
Associate Professor Seokheun “Sean” Choi — a faculty member in the Department of Electrical and Computer Engineering at Binghamton University’s Thomas J. Watson College of Engineering and Applied Science — is researching a faster way to test bacteria for antibiotic resistance.
“To effectively treat the infections, we need to select the right antibiotics with the exact dose for the appropriate duration,” he said. “There’s a need to develop an antibiotic-susceptibility testing method and offer effective guidelines to treat these infections.”
In the past few years, Choi has developed several projects that cross “papertronics” with biology, such as one that developed biobatteries using human sweat.
This new research — titled “A simple, inexpensive, and rapid method to assess antibiotic effectiveness against exoelectrogenic bacteria” and published in November’s issue of the journal Biosensors and Bioelectronics — relies on the same principles as the batteries: Bacterial electron transfer, a chemical process that certain microorganisms use for growth, overall cell maintenance and information exchange with surrounding microorganisms.
“We leverage this biochemical event for a new technique to assess the antibiotic effectiveness against bacteria without monitoring the whole bacterial growth,” Choi said. “As far as I know, we are the first to demonstrate this technique in a rapid and high-throughput manner by using paper as a substrate.”
Working with PhD students Yang Gao (who earned his degree in May and is now working as a postdoctoral researcher at the University of Texas at Austin), Jihyun Ryu and Lin Liu, Choi developed a testing device that continuously monitors bacteria’s extracellular electron transfer.
A medical team would extract a sample from a patient, inoculate the bacteria with various antibiotics over a few hours and then measure the electron transfer rate. A lower rate would mean that the antibiotics are working.
“The hypothesis is that the antiviral exposure could cause sufficient inhibition to the bacterial electron transfer, so the readout by the device would be sensitive enough to show small variations in the electrical output caused by changes in antibiotic effectiveness,” Choi said.
The device could provide results about antibiotic resistance in just five hours, which would serve as an important point-of-care diagnostic tool, especially in areas with limited resources.
The prototype — built in part with funding from the National Science Foundation and the U.S. Office of Naval Research — has eight sensors printed on its paper surface, but that could be extended to 64 or 96 sensors if medical professionals wanted to build other tests into the device.
Building on this research, Choi already knows where he and his students would like to go next: “Although many bacteria are energy-producing, some pathogens do not perform extracellular electron transfer and may not be used directly in our platform. However, various chemical compounds can assist the electron transfer from non-electricity-producing bacteria.
“For instance, E. coli cannot transfer electrons from the inside of the cell to the outside, but with the addition of some chemical compounds, they can generate electricity. Now we are working on how to make this technique general to all bacteria cells.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Bacterial infections
- Imbalances in gut bacteria linked to ‘long COVID’ risk: Studyon January 12, 2021 at 12:31 pm
Imbalances in the type and volume of bacteria found in the gut may be associated with the risk of 'long COVID', the symptoms of which ...
- Bacteria in your GUT affects your immune response to Covid-19 and could influence how severely you suffer symptoms, study findson January 12, 2021 at 10:00 am
A review study from South Korea and a real-world study from China determined the gut microbiome plays a role in coronavirus disease severity.
- Gut Bacteria May Impact Severity Of COVID-19 Infectionson January 12, 2021 at 9:16 am
The trillions of microorganisms that live in your gut might play a role in how well you cope with COVID-19, as per a new study. Equally, gut bacteria might ...
- Health Matters: Many types of fungal infectionson January 12, 2021 at 6:10 am
Viral infections are big news, with the COVID-19 virus being a current topic of discussion. The latest iteration of a corona virus infestation has gone beyond epidemic proportions, resulting in our ...
- Intestinal bacteria may affect severity of COVID-19, researchers findon January 12, 2021 at 4:48 am
The bacteria lurking in COVID-19 patients’ intestines may play a role in how sick they get from the illness, according to new research. Although the coronavirus is primarily a respiratory disease, ...
Go deeper with Google Headlines on:
Bacterial infections
Go deeper with Bing News on:
Antibiotic-resistant bacteria
- 5N Plus Acquires Stake in Microbion and Secures Drug Substance Manufacturing Rightson January 12, 2021 at 3:12 am
CNW/ - 5N Plus Inc. ("5N Plus"), a leading global producer of specialty chemicals and engineered materials, and Microbion Corporation ("Microbion"), a clinical-stage pharmaceutical company focused on ...
- Controlling Nanomaterial Surface Texture to Kill Drug-Resistant Bacteriaon January 12, 2021 at 2:13 am
The COVID-19 pandemic has been increasing the fears of new pathogens like drug-resistant bacteria or new viruses. A Korean research group has recently gained attention for designing a new technology ...
- Bacteria-killing viruses could stop the rise of deadly superbugson January 11, 2021 at 3:54 pm
Researchers have found a way to revert antibiotic resistance in one of the world's most dangerous hospital-acquired infections.
- Researchers provide new insights into how antibiotic resistance developson January 11, 2021 at 10:17 am
Researchers at the Quadram Institute on the Norwich Research Park have shown how the development of antibiotic resistance by bacteria can have 'side-effects' for them including affecting their ability ...
- Research provides better understanding of how antibiotic resistance ariseson January 11, 2021 at 4:31 am
Researchers at the Quadram Institute on the Norwich Research Park have shown how the development of antibiotic resistance by bacteria can have 'side-effects' for them including affecting their ability ...